LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Shanghai Minbiotech
03 1Beijing Mesochem Technology
04 1Patheon
05 1Takeda Pharmaceutical
01 2China
02 1Japan
03 2U.S.A
01 5Blank
01 5Blank
01 5Blank
01 5Blank
01 5Blank
01 111532-3002
02 168225-240
03 3Blank
01 5Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Mesochem is focused on incessant innovation along with the R&D of new APIs.
NDC Package Code : 68225-240
Start Marketing Date : 2014-05-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (300mg/5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-3002
Start Marketing Date : 2014-05-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (300mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 5 companies offering Vedolizumab
Get in contact with the supplier of your choice:
